Precigen, Inc. (PGEN)
6.555
+0.17
(+2.66%)
USD |
NASDAQ |
Oct 19, 14:06
Precigen Cash from Operations (Annual) : -87.83M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -87.83M |
| December 31, 2024 | -68.17M |
| December 31, 2023 | -66.93M |
| December 31, 2022 | -65.04M |
| December 31, 2021 | -55.77M |
| December 31, 2020 | -77.02M |
| December 31, 2019 | -135.93M |
| December 31, 2018 | -124.24M |
| Date | Value |
|---|---|
| December 31, 2017 | -104.14M |
| December 31, 2016 | -48.99M |
| December 31, 2015 | 35.67M |
| December 31, 2014 | -19.86M |
| December 31, 2013 | -53.68M |
| December 31, 2012 | -61.53M |
| December 31, 2011 | -81.76M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Anika Therapeutics, Inc. | 11.19M |
| Aldeyra Therapeutics, Inc. | -33.35M |
| Repligen Corp. | 117.42M |
| AC Immune SA | -83.40M |
| Amgen, Inc. | 9.958B |